Literature DB >> 8944218

Lovastatin-associated dermatomyositis.

J L Rodriguez-Garcia, M Serrano Commino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8944218      PMCID： PMC2398616          DOI： 10.1136/pgmj.72.853.694

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  6 in total

1.  Pravastatin-associated inflammatory myopathy.

Authors:  B B Schalke; B Schmidt; K Toyka; H P Hartung
Journal:  N Engl J Med       Date:  1992-08-27       Impact factor: 91.245

2.  Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin.

Authors:  D J Norman; D R Illingworth; J Munson; J Hosenpud
Journal:  N Engl J Med       Date:  1988-01-07       Impact factor: 91.245

3.  The role of cholesterol-lowering agents in drug-induced rhabdomyolysis and polymyositis.

Authors:  J A Goldman; A B Fishman; J E Lee; R J Johnson
Journal:  Arthritis Rheum       Date:  1989-03

4.  Simvastatin-associated dermatomyositis.

Authors:  F H Khattak; I M Morris; W A Branford
Journal:  Br J Rheumatol       Date:  1994-02

Review 5.  Lovastatin-induced rhabdomyolysis in the absence of concomitant drugs.

Authors:  C S Wallace; B A Mueller
Journal:  Ann Pharmacother       Date:  1992-02       Impact factor: 3.154

Review 6.  Drug-related myopathies.

Authors:  J Zuckner
Journal:  Rheum Dis Clin North Am       Date:  1994-11       Impact factor: 2.670
  6 in total
  6 in total

1.  Gottron's papules-like eruption developing under hydroxyurea therapy.

Authors:  Gleb Slobodin; Michael Lurie; Mariana Munichor; Julia Kovalev; Itzhak Rosner
Journal:  Rheumatol Int       Date:  2006-04-01       Impact factor: 2.631

2.  Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.

Authors:  Liam R Brunham; Steven Baker; Andrew Mammen; G B John Mancini; Robert S Rosenson
Journal:  Cardiovasc Res       Date:  2018-07-01       Impact factor: 10.787

Review 3.  Update on toxic myopathies.

Authors:  F L Mastaglia; M Needham
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

Review 4.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

Review 5.  Lipid-lowering agent-triggered dermatomyositis and polymyositis: a case series and literature review.

Authors:  Isabela Bruna Pires Borges; Marilda Guimarães Silva; Rafael Giovane Misse; Samuel Katsuyuki Shinjo
Journal:  Rheumatol Int       Date:  2017-10-12       Impact factor: 2.631

Review 6.  Anti-HMGCR Myopathy.

Authors:  Payam Mohassel; Andrew L Mammen
Journal:  J Neuromuscul Dis       Date:  2018
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.